Previous studies on DCs and MS revealed that monocyte-derived DCs from patients produce higher levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) than healthy subjects [14]. Here, IL6 is linked to myeloid sarcoma.